Syros Pharmaceuticals Inc. buy BiotechBee
Start price
24.06.23
/
50%
€2.68
Target price
31.12.25
€4.00
Performance (%)
36.94%
End price
01.10.23
€3.67
Summary
This prediction ended on 01.10.23 with a price of €3.67. With a performance of 36.94% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Syros Pharmaceuticals Inc. where he still thinks Syros Pharmaceuticals Inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Syros Pharmaceuticals Inc. | -11.364% | -11.364% | -58.730% |
| iShares Core DAX® | 2.758% | 0.818% | 17.073% |
| iShares Nasdaq 100 | 2.595% | -1.326% | 31.625% |
| iShares Nikkei 225® | 3.109% | 0.173% | 17.176% |
| iShares S&P 500 | 1.862% | -0.531% | 26.703% |
According to BiotechBee what are the pros and cons of Syros Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Syros Pharmaceuticals Inc diskutieren
In the thread Trading Syros Pharmaceuticals Inc
Current prediction by BiotechBee for Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.67
04.12.23
04.12.23
€4.00
30.11.25
30.11.25
-41.57%
20.08.24
20.08.24
Could be very worthwhile Investment >20% year
